Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

EURO-SKI Investigators

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalLancet Oncology
Volume19
Issue number6
Pages (from-to)747-757
Number of pages11
ISSN1470-2045
DOIs
Publication statusPublished - Jun 2018
MoE publication typeA1 Journal article-refereed

Fields of Science

  • MAJOR MOLECULAR RESPONSE
  • TREATMENT-FREE REMISSION
  • IMATINIB DISCONTINUATION
  • WITHDRAWAL SYNDROME
  • PHASE-2 TRIAL
  • FOLLOW-UP
  • SURVIVAL
  • DASATINIB
  • NILOTINIB
  • DISEASE
  • 3122 Cancers

Cite this